Oral Antibiotics for Treatment of Gram-Negative Bacteremia in Solid Organ Transplant Recipients: A Propensity Score Weighted Retrospective Observational Study

被引:2
|
作者
Nussbaum, Eliezer Zachary [1 ,4 ]
Koo, Sophia [2 ]
Kotton, Camille N. [3 ]
机构
[1] Tufts Med Ctr, Dept Geog Med & Infect Dis, Boston, MA USA
[2] Brigham & Womens Hosp, Div Infect Dis, Boston, MA USA
[3] Massachusetts Gen Hosp, Dept Infect Dis, Boston, MA USA
[4] Tufts Univ, Tufts Med Ctr, Dept Geog Med & Infect Dis, Sch Med, 800 Washington St,Holmes Bldg Off 509, Boston, MA 02111 USA
关键词
solid organ transplant; bacteremia; oral antibiotics; immunocompromised host; THERAPY; TRIAL;
D O I
10.1093/cid/ciae007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background We assessed the safety and efficacy of oral antibiotic step-down therapy for uncomplicated gram-negative blood stream infections in solid-organ transplant recipients.Methods We identified all solid-organ transplant recipients within the Massachusetts General and Brigham and Women's Hospital systems from 2016 to 2021 with uncomplicated gram-negative bacteremia involving an organism susceptible to an acceptably bioavailable oral antibiotic agent. Using inverse probability of treatment-weighted models based on propensity scores adjusting for potential clinical confounders, we compared outcomes of those transitioned to oral antibiotics with those who continued intravenous (IV) therapy for the duration of treatment. Primary endpoints were mortality, bacteremia recurrence, and reinitiation of IV antibiotics. Secondary endpoints included length of stay, Clostridioides difficile infection, treatment-associated complications, and tunneled central venous catheter placement.Results A total of 120 bacteremia events from 107 patients met inclusion criteria in the oral group and 42 events from 40 patients in the IV group. There were no significant differences in mortality, bacteremia recurrence, or reinitiation of IV antibiotics between groups. Patients transitioned to oral antibiotics had an average length of stay that was 1.97 days shorter (95% confidence interval [CI], -.39 to 3.56 days; P = .005). Odds of developing C. difficile and other treatment-associated complications were 8.4 times higher (95% CI, 1.5-46.6; P = .015) and 6.4 times higher (95% CI, 1.9-20.9; P = .002), respectively, in the IV group. Fifty-five percent of patients in the IV group required tunneled catheter placement. There was no difference in treatment duration between groups.Conclusions Oral step-down therapy was effective and associated with fewer treatment-related adverse events. In solid-organ transplant recipients, treatment of uncomplicated gram-negative bloodstream infections with oral antibiotics was safe, effective, and associated with fewer adverse events and shorter length of hospital stay compared with continued intravenous treatment. Graphical Abstract This graphical abstract is also available at Tidbit: https://tidbitapp.io/tidbits/oral-antibiotics-for-treatment-of-gram-negative-bacteremia-in-solid-organ-transplant-recipients-a-propensity-score-weighted-retrospective-observational-study
引用
收藏
页码:208 / 214
页数:7
相关论文
共 50 条
  • [31] Prognostic Outcomes of Cutaneous Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Retrospective Comparative Cohort Study
    Salido-Vallejo, Rafael
    Escribano-Castillo, Lourdes
    Antonanzas, Javier
    Roldan-Cordoba, Claudia
    Velez, Antonio
    Aguado-Gil, Leyre
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (24)
  • [32] Sulfonamide allergy label and the risk of opportunistic infections in solid organ transplant recipients - A retrospective matched cohort study
    Al-Shaikhly, Taha
    Al-Obaydi, Sarah
    Craig, Timothy J.
    Henao, Maria P.
    TRANSPLANT INFECTIOUS DISEASE, 2024, 26 (05)
  • [33] Assessing Clinician Utilization of Next-Generation Antibiotics Against Resistant Gram-Negative Infections in US Hospitals: A Retrospective Cohort Study
    Strich, Jeffrey R.
    Mishuk, Ahmed
    Diao, Guoqing
    Lawandi, Alexander
    Li, Willy
    Demirkale, Cumhur Y.
    Babiker, Ahmed
    Mancera, Alex
    Swihart, Bruce J.
    Walker, Morgan
    Yek, Christina
    Neupane, Maniraj
    De Jonge, Nathaniel
    Warner, Sarah
    Kadri, Sameer S.
    ANNALS OF INTERNAL MEDICINE, 2024, 177 (05)
  • [34] Ganciclovir-resistant cytomegalovirus infection in solid organ transplant recipients: a single-center retrospective cohort study
    Young, P. G.
    Rubin, J.
    Angarone, M.
    Flaherty, J.
    Penugonda, S.
    Stosor, V.
    Ison, M. G.
    TRANSPLANT INFECTIOUS DISEASE, 2016, 18 (03) : 390 - 395
  • [35] Trimethoprim/sulfamethoxazole for nocardiosis in solid organ transplant recipients: Real-life data from a multicentre retrospective study
    Conan, Pierre-Louis
    Matignon, Marie
    Bleibtreu, Alexandre
    Guillot, Helene
    Van Laecke, Steven
    Brenier, Henri
    Crochette, Romain
    Melica, Giovanna
    Fernandez-Ruiz, Mario
    Dantal, Jacques
    Walti, Laura N.
    Levi, Charlene
    Chauvet, Cecile
    De Greef, Julien
    Marbus, Sierk D.
    Mueller, Nicolas J.
    Ieven, Margareta
    Vuotto, Fanny
    Lortholary, Olivier
    Coussement, Julien
    Lebeaux, David
    TRANSPLANT INFECTIOUS DISEASE, 2021,
  • [36] Lessons Learned From a Randomized Study of Oral Valganciclovir Versus Parenteral Ganciclovir Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients: The VICTOR Trial
    Asberg, Anders
    Humar, Atul
    Rollag, Halvor
    Jardine, Alan G.
    Kumar, Deepali
    Aukrust, Pal
    Ueland, Thor
    Bignamini, Angelo A.
    Hartmann, Anders
    CLINICAL INFECTIOUS DISEASES, 2016, 62 (09) : 1154 - 1160
  • [37] Revision Total Hip Arthroplasty in Solid Organ Transplant Patients: A Propensity Score-Matched Cohort Study for Aseptic and Infected Revisions
    Upfill-Brown, Alex
    Hart, Christopher M.
    Hsiue, Peter P.
    Burgess, Kadarius
    Chen, Clark J.
    Khoshbin, Amir
    Photopoulos, Christos
    Stavrakis, Alexandra I.
    ARTHROPLASTY TODAY, 2022, 14 : 6 - 13
  • [38] Periodontal status and bacteremia with oral viridans streptococci and coagulase negative staphylococci in allogeneic hematopoietic stem cell transplantation recipients: a prospective observational study
    Judith E. Raber-Durlacher
    Alexa M. G. A. Laheij
    Joel B. Epstein
    Matthew Epstein
    Gerard M. Geerligs
    Gordon N. Wolffe
    Nicole M. A. Blijlevens
    J. Peter Donnelly
    Supportive Care in Cancer, 2013, 21 : 1621 - 1627
  • [39] Periodontal status and bacteremia with oral viridans streptococci and coagulase negative staphylococci in allogeneic hematopoietic stem cell transplantation recipients: a prospective observational study
    Raber-Durlacher, Judith E.
    Laheij, Alexa M. G. A.
    Epstein, Joel B.
    Epstein, Matthew
    Geerligs, Gerard M.
    Wolffe, Gordon N.
    Blijlevens, Nicole M. A.
    Donnelly, J. Peter
    SUPPORTIVE CARE IN CANCER, 2013, 21 (06) : 1621 - 1627
  • [40] Risk Factors and Outcome of Gram-Negative Bloodstream Infection in Living-Donor Renal Transplant Recipients: A Case-Control Study From Pakistan
    Nasim, Asma
    Dodani, Sunil Kumar
    Rehman, Muniba
    Babar, Zaheer Udin
    Badlani, Sanjay
    Mushtaq, Maryam
    Aziz, Tahir
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2023, 21 (07) : 562 - 567